Increased expression of c-Met correlates with resistance to platinum-based agents, radiation, and to EGFR-targeting agents; given that most HNSCC samples overexpress c-Met, this may be a novel therapeutic target [31]. Here, EGFR is linked to head and neck squamous cell carcinoma.